Bladder cancer vaccine - Memorial Sloan-Kettering Cancer Center
Latest Information Update: 15 Aug 2007
Price :
$50 *
At a glance
- Originator Memorial Sloan-Kettering Cancer Center
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer
Most Recent Events
- 17 Jul 2001 No-Development-Reported for Bladder cancer in USA (Unknown route)
- 03 Feb 1995 Preclinical development for Bladder cancer in USA (Unknown route)